Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonergic involvement in conflict behaviour.

B Söderpalm1, J A Engel

  • 1Department of Pharmacology, University of Göteborg, Sweden.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-contingent influence over accumbal neurotransmission and the locomotor stimulatory response to acute and repeated administration of nicotine in Wistar rats.

Neuropharmacology·2015
Same author

The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence.

Translational psychiatry·2015
Same author

Region-specific depression of striatal activity in Wistar rat by modest ethanol consumption over a ten-month period.

Alcohol (Fayetteville, N.Y.)·2013
Same author

Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents.

Neuroscience·2010
Same author

Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system.

Pharmacopsychiatry·2009
Same author

Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms.

Endocrinology·2001
Same journal

Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Corrigendum to "Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults" [European Neuropsychopharmacology, 112, 112887].

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Variability in AI-generated psychedelic definitions across major chatbots.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

In-patient treatment and structural dysconnectivity in major depression - A longitudinal connectome study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
See all related articles

Manipulating brain serotonin (5-HT) systems can yield both anxiety-reducing and anxiety-promoting effects in animal models. These effects depend on the specific drug and dose, influencing the 5-HT system in complex ways.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • The serotonergic (5-HT) system plays a crucial role in regulating mood and behavior.
  • Understanding 5-HT system modulation is key to developing treatments for anxiety disorders.

Purpose of the Study:

  • To investigate the anxiolytic and anxiogenic effects of various 5-HT system manipulations in an animal model of anxiety.
  • To explore the involvement of the GABAA/benzodiazepine receptor complex in 5-HT-mediated anxiety responses.

Main Methods:

  • Utilized Montgomery's conflict test, an animal model assessing anxiety through exploration-fear conflict.
  • Administered 5-HT1A receptor agonists (buspirone, gepirone, ipsapirone, 8-OH-DPAT), 5-HT precursor (L-5-HTP), and 5-HT depleting agents (PCPA, 5,7-DHT).
  • Employed a modified Vogel's conflict test and receptor antagonists (flumazenil, bicuculline) to assess GABAA/benzodiazepine involvement.

Related Experiment Videos

Main Results:

  • 5-HT1A agonists showed anxiolytic-like effects at low doses and returned to baseline or suppressed behavior at higher doses.
  • L-5-HTP exhibited a biphasic effect: anxiolytic at low doses and anxiogenic at high doses.
  • PCPA and 5,7-DHT produced anxiolytic-like effects, which were counteracted by flumazenil and bicuculline, suggesting GABAA/benzodiazepine receptor involvement.

Conclusions:

  • Brain 5-HT neurotransmission modulation can induce both anxiolytic and anxiogenic effects in conflict-based animal models.
  • Anxiolytic effects are suggested to stem from decreased 5-HT neurotransmission, while anxiogenic effects may arise from increased 5-HT neurotransmission.
  • The anxiolytic effects of 5-HT depletion involve the GABAA/benzodiazepine chloride ionophore receptor complex.